Comparative Trial of a New Anticholinergic Bronchodilator, Sch 1000, and Salbutamol in Chronic Bronchitis
H Poppius, Yrjö Salorinne
Abstract
Open-access reader
H Poppius, Yrjö Salorinne
Abstract
Open-access reader
In 20 patients with chronic bronchitis and moderate or severe airways obstruction inhalation of 40 mug of a new anticholinergic drug, Sch 1000, was found to produce stronger and more persistent bronchodilation than inhalation of 200 mug of salbutamol.
OpenAlex reports 85 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
In 20 patients with chronic bronchitis and moderate or severe airways obstruction inhalation of 40 mug of a new anticholinergic drug, Sch 1000, was found to produce stronger and more persistent bronchodilation than inhalation of 200 mug of salbutamol.
Key concepts: Salbutamol, Bronchodilation, Anticholinergic, Bronchodilator, Medicine, Chronic bronchitis, Inhalation, Bronchitis